Pneumococcal Vaccines

Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae*

Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae* Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations

Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae*

They function by exposing the host immune system to capsular polysaccharides—either alone or conjugated to an immunogenic carrier protein to elicit a T-cell–dependent response—thereby stimulating the production of serotype-specific protective antibodies and immunological memory

Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations

Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations

Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations

Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations